Navigation Links
Researchers Find Gene Mutations That May Be a Key to Autism
Date:4/4/2012

By Carina Storrs
HealthDay Reporter

WEDNESDAY, April 4 (HealthDay News) -- Genetic mutations that arise spontaneously, as opposed to being passed through generations, could play an important role in the development of autism, new research suggests.

Three research teams sequenced the genes of children with sporadic autism, meaning it did not run in their families, and compared the sequences with those of their parents and siblings. Their results were published in three separate articles on April 4 in the journal Nature.

"We found that 15 to 20 percent of sporadic patients could be explained by 'de novo' [or spontaneous] mutations," said Evan Eichler, professor of genome sciences at the University of Washington in Seattle, who led one of the studies.

Overall, the researchers identified hundreds of spontaneous mutations in gene sequences that they predicted would upset the function of the genes in the children with autism. Most of them were only found in single patients.

The good news, according to Eichler, is that the multitude of affected genes seems to belong to just a handful of pathways -- involved in, for example, development or cognition. That suggests that mutations in a diverse set of genes could have a similar biological effect.

"This kind of investigation is of tremendous value for understanding the genetic architecture of risk for autism," said Andy Shih, vice president of scientific affairs at Autism Speaks, a national advocacy group.

"We can probably explain genetic risk factors that might lead to autism in less than 30 percent of the population" from previous research, Shih added.

Autism spectrum disorders, which include both mild and serious forms of autism, affect one in 88 children in the United States, according to just-updated statistics from the U.S. Centers for Disease Control and Prevention.

The study led by Eichler involved 677 individuals representing 209 different families, each with one child who had sporadic autism. The researchers found a total of 126 spontaneous mutations that they predicted would have a severe effect on the genes in which they occurred.

Eichler's team relied on samples from the Simons Simplex Collection, a nationwide project that gathers blood and DNA from children with sporadic autism and their unaffected family members.

A second study, led by researchers at Yale University in New Haven, Conn., looked at 238 families from the Simons project, some of which overlapped with Eichler's study. They identified 125 de novo mutations that would change the readout of genes among the children with autism and 87 among their unaffected siblings.

The third study in the trio found that just under half of children, both with and without autism, had readout-altering spontaneous mutations, but that the mutation rate was comparable between children with autism and their unaffected siblings. This study was led by researchers at Harvard Medical School, Massachusetts General Hospital in Boston and the Broad Institute in Cambridge, Mass., and involved 175 sets of children with autism and their parents.

Altogether, this body of research suggests that the frequency of de novo mutations is not significantly higher in children with autism, but that the types of mutations, which occur by chance, are more detrimental in children with autism than those in their unaffected siblings, Eichler said.

Eichler's team also found that de novo mutations were four times as likely to lie on DNA strands inherited from the father, and that the number of mutations increases with paternal age.

The possible paternal influence suggests that many of the de novo mutations originate in the father's sex cells, which give rise to sperm. Presumably, mutations would be more likely in paternal sex cells rather than maternal ones because paternal cells continue to divide throughout a man's lifetime, giving them more chances to pick up mutations.

Although the link with paternal age agrees with some epidemiological studies that have found higher rates of autism among children of older parents, it probably only plays a part in a modest 10 percent or so of patients, Eichler said.

From the three studies, mutations in two genes, called CHD8 and KATNAL2, emerged as likely autism risk factors because they were found in more than one patient. "Almost never did we see lightning strike the same place twice," Eichler said.

Unlike the myriad mutations identified in genes involved in neuronal development, these mutations could have more universal effects on regulating gene expression, cell growth and differentiation.

These two genes were also among the 49 genes that fell into the same biological pathway, Eichler's team found. "This one is a monster pathway," Eichler said, because it involves the largest number of identified de novo mutations.

The gene mutations identified in this research "underscores that autism is a complex interplay between genes and the environment," Shih said. For example, CHD8 can control the expression of other genes in response to environmental stimuli.

This research is also a reminder that autism is a group of related disorders involving many genes in different pathways, he added. "Each of the genes [in these studies] seem to confer only a small risk, and are only readily found in a small percentage of individuals with autism," he noted.

However, Shih said, these studies show that with more genetic analyses involving more patients, "there could be some unifying principles revealed that could allow identification of individuals at risk of autism and guide therapeutics."

More information

To learn more about autism, visit the Autism Society of America.

SOURCES: Evan Eichler, Ph.D., professor, genome sciences, University of Washington, Seattle; Andy Shih, Ph.D., vice president, scientific affairs, Autism Speaks, New York City; April 4, 2012, Nature


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. NIH awards $20 million over 5 years to train next generation of global health researchers
4. Researchers identify a gene that predicts recurrence in squamous cell carcinoma of the head and neck
5. Researchers uncover new clues to the development of blood and other cancers
6. Researchers work to help soldiers break camouflage
7. Researchers identify mechanism that makes breast cancer invasive
8. Penn researchers call for a re-examination of transplant waitlist prioritization
9. Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke
10. NIH researchers highlight progress, path forward for developing TB vaccines
11. Penn researchers find mentoring provides health benefits for African American veterans with diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Find Gene Mutations That May Be a Key to Autism
(Date:5/24/2017)... , ... May 24, 2017 , ... Myers Jackson is ... has the ability to sell luxury homes anywhere on the planet. The luxury home ... side from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... addition of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered ... of every IT system, from the datacenter to the cloud to the edge. ...
(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs ... hospitals and health systems in the nation and help their organizations navigate the ... organizations and been instrumental in developing successful hospital and health system strategy. , ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International ... company, announced today that its iClinic V12.2 solution has achieved approval from National ... recently introduced PCMH 2017 standards which emphasize team-based care with a significant focus ...
(Date:5/23/2017)... ... 2017 , ... Cambridge, MA, May 23, 2017—Total costs per ... a Workers Compensation Research Institute (WCRI) study, a contrast from the increases of ... Benchmarks, 17th Edition looks at indemnity and medical payments for workers’ compensation ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
Breaking Medicine Technology: